Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KALV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in KalVista Pharmaceuticals Inc stock price on Wednesday moving 10.31% between high and low
(Updated on May 01, 2024)

Buy candidate since May 01, 2024 PDF

The KalVista Pharmaceuticals Inc stock price gained 7.31% on the last trading day (Wednesday, 1st May 2024), rising from $11.35 to $12.18. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.31% from a day low at $11.35 to a day high of $12.52. The price has risen in 6 of the last 10 days and is up by 4.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 166 thousand more shares were traded than the day before. In total, 480 thousand shares were bought and sold for approximately $5.85 million.

Given the current short-term trend, the stock is expected to fall -27.19% during the next 3 months and, with a 90% probability hold a price between $7.26 and $8.87 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KALV Signals & Forecast

The KalVista Pharmaceuticals Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $11.05 and $11.54. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 17.68%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for KalVista Pharmaceuticals Inc stock

KalVista Pharmaceuticals Inc finds support from accumulated volume at $11.93 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.17 between high and low, or 10.31%. For the last week, the stock has had daily average volatility of 5.38%.

Our recommended stop-loss: $11.70 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (KALV) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect KalVista Pharmaceuticals Inc to open at $12.02, and during the day (based on 14 day Average True Range), to move between $11.56 and $12.80, which gives a possible trading interval of +/-$0.621 (+/-5.10%) up or down from last closing price. If KalVista Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.93 (2.05%) than the resistance at $12.58 (3.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is KalVista Pharmaceuticals Inc stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 3.431 Buy Candidate Upgraded

Predicted Opening Price for KalVista Pharmaceuticals Inc of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$12.02 ( 1.34%) $12.18

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KALV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 13.19 8.26 %
R2 12.74 4.60 %
R1 12.46 2.33 %
Current price: 12.18
Support S1 11.57 -5.01 %
S2 11.29 -7.28 %
S3 10.85 -10.95 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 14.85 21.92 %
R2 14.76 21.18 %
R1 12.58 3.28 %
Current price 12.18
Support S1 11.93 -2.05%
S2 11.86 -2.63%
S3 11.04 -9.36%

FAQ

What is the symbol for KalVista Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for KalVista Pharmaceuticals Inc is KALV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell KalVista Pharmaceuticals Inc Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy KalVista Pharmaceuticals Inc Stock.

What's the current price of KalVista Pharmaceuticals Inc Stock?
As of the end of day on the May 01, 2024, the price of an KalVista Pharmaceuticals Inc (KALV) share was $12.18.

What is the 52-week high and low for KalVista Pharmaceuticals Inc Stock?
The 52-week high for KalVista Pharmaceuticals Inc Stock is $16.88 and the 52-week low is $7.21.

What is the market capitalization of KalVista Pharmaceuticals Inc Stock?
As of the May 01, 2024, the market capitalization of KalVista Pharmaceuticals Inc is 513.853M.

When is the next earnings date for KalVista Pharmaceuticals Inc?
The upcoming earnings date for KalVista Pharmaceuticals Inc is Jul 05, 2024.
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT